soul trial oral semaglutide cardiovascular outcomes nejm 2025 results SOUL: Bests Usual Care in High-Risk Type 2 Diabetes NEJM Editorial Fellow Harleen Marwah,
Pay in 4 interest-free payments of $5.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28

























